Advancements in MRSA treatment: the role of berberine in enhancing antibiotic therapy.

ABSTRACT:

Background

Methicillin-resistant Staphylococcus aureus (MRSA) is a significant public health problem. This study investigated the antimicrobial properties and mechanisms of berberine (BBR), a plant alkaloid, against MRSA, evaluating its potential to enhance antibiotic therapy.

Results

Berberine only demonstrated variable but significant inhibitory effects on 50 clinical MRSA strains. When combined with antibiotics, synergistic effects were observed only with amikacin in 6 of the 50 MRSA strains. BBR disrupted MRSA cell wall integrity, leading to leakage of cellular contents. Network pharmacology analysis revealed that BBR targets multiple pathways essential for bacterial survival.

Conclusion

The study confirmed the potent antimicrobial activity of berberine against MR

SUBMITTER: Zhou F 

PROVIDER: S-EPMC11674092 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature